Learn / OCUL
NASDAQ: OCUL
Ocular Therapeutix (OCUL) stock, explained like you're 5
Ocular Therapeutix trades on the Nasdaq under the ticker OCUL. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 1.7 billion dollars.
- Ticker
- OCUL
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations
- Size
- Small cap, about 1.7 billion dollars
Is Ocular Therapeutix a small, medium or large cap company?
No. Ocular Therapeutix is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 1.7 billion dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Ocular Therapeutix makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves OCUL stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- Ocular Therapeutix (OCUL) Stock May Be Fully Priced Given Its Sales Base (Simply Wall Street)
- OCUL Stock In Spotlight After Q2 Loss Comes In Narrower Than Estimated A Look At Key Highlights (Stocktwits)
- Is Ocular Therapeutix (OCUL) Stock a Buy Ahead of Its Major NDA Catalyst? (Yahoo Finance)
- Ocular Therapeutix, Inc. (OCUL) Presents at American Academy of Ophthalmology Retina Subspeciality Day Slideshow (NASDAQ:OCUL) 2026 10 15 (Seeking Alpha)
- Ocular Therapeutix CLO Todd Anderman sells $87,363 in company stock (Investing.com)
Follow OCUL in your daily brief
Each trading day at 5 PM ET we post what happened to Ocular Therapeutix and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow OCUL
Questions about Ocular Therapeutix stock
What does Ocular Therapeutix do?
Ocular Therapeutix trades on the Nasdaq under the ticker OCUL. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 1.7 billion dollars.
What is the ticker symbol for Ocular Therapeutix?
Ocular Therapeutix trades under the ticker OCUL on the Nasdaq.
What is Ocular Therapeutix's market cap?
Ocular Therapeutix is a small cap stock with a market cap of about 1.7 billion dollars.
How does Ocular Therapeutix make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves OCUL stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow OCUL stock every day?
Add OCUL to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.